Luis Miguel
Antón Aparicio
Hospital Universitario de Salamanca
Salamanca, EspañaPublicacións en colaboración con investigadores/as de Hospital Universitario de Salamanca (2)
2012
-
MicroRNA expression profiling of peripheral blood samples predicts resistance to first-line sunitinib in advanced renal cell carcinoma patients
Neoplasia (United States), Vol. 14, Núm. 12, pp. 1144-1152
2004
-
Phase II study of UFT and oxaliplatin in first-line treatment of advanced colorectal cancer
British Journal of Cancer, Vol. 91, Núm. 10, pp. 1758-1762